Clinical Research FDA Approval Life Science Pharma Companies 
XTalks
DECEMBER 20, 2023
In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.
XTalks
AUGUST 18, 2020
The study was funded by a clinical research agreement with the NBA and the players’ union – the National Basketball Players Association (NDG) – which together, contributed over $500,000 to fund the Yale study. Last month, the FDA approved a pooled test for COVID-19 developed by Quest Diagnostics. It’s sensitive.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
FEBRUARY 1, 2022
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?
pharmaphorum
MARCH 2, 2022
There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments. The image of psychedelic drugs within medical research is changing. A psychedelic renaissance.
pharmaphorum
AUGUST 31, 2021
For the innovators and early adopters of the life sciences industry, engineering a regulatory-grade ECA can be daunting. However, if history is any indication, pharma companies have been risk-averse when it comes to fully immersing itself into the expanded use of RWE in our development efforts.
pharmaphorum
JULY 8, 2022
Pharma companies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption. It needs to be performed with a benchmark, an FDA-approved device.”. Novel digital endpoints. About the interviewees. About the author.
Cloudbyz
MAY 19, 2021
Introduction Cell and gene therapy is an upcoming wave of therapeutic innovation in the healthcare and life sciences industry and is being pragmatically accepted worldwide. The gene therapy market reported its first market approvals back in 2017 and the evolution has been extensive ever since.
Expert insights. Personalized for you.
59 
Let's personalize your content